CASI Pharmaceuticals
CASI
#9670
Rank
S$55.58 M
Marketcap
$3.59
Share price
4.80%
Change (1 day)
-47.02%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -S$39.52 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are S$22.05 Million. In 2023 the company made an earning of -S$36.12 Million, an increase over its 2022 earnings that were of -S$51.27 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$39.52 Million9.4%
2023 -S$36.12 Million-29.55%
2022 -S$51.27 Million4.43%
2021 -S$49.09 Million-24.56%
2020 -S$65.07 Million4.74%
2019 -S$62.13 Million65.13%
2018 -S$37.63 Million155.07%
2017 -S$14.75 Million13.93%
2016 -S$12.95 Million31.18%
2015 -S$9.87 Million-72.5%
2014 -S$35.89 Million356.62%
2013 -S$7.86 Million-60.55%
2012 -S$19.92 Million218.41%
2011 -S$6.26 Million0.74%
2010 -S$6.22 Million-32.54%
2009 -S$9.21 Million-66.98%
2008 -S$27.88 Million-14.22%
2007 -S$32.5 Million7.04%
2006 -S$30.37 Million27.95%
2005 -S$23.73 Million4.51%
2004 -S$22.71 Million-15.84%
2003 -S$26.98 Million-55.29%
2002 -S$60.35 Million-34.05%
2001 -S$91.5 Million31.73%
2000 -S$69.46 Million31.56%
1999 -S$52.8 Million145.56%
1998 -S$21.51 Million76.4%
1997 -S$12.19 Million36.92%
1996 -S$8.91 Million